Industry News
Inhibition of lactate enzyme prevents expansion of aggressive cancer initiating cells in lung cancer model
Apr 14, 2014
Cancer cells generate energy differently than normal cells, a characteristic that helps them to survive and metastasize. Read More
Transcription factors identified that distinguish glioblastoma stem cells
Apr 14, 2014
The activity of four transcription factors - proteins that regulate the expression of other genes - appears to distinguish the small proportion of glioblastoma cells responsible for the... Read More
Study highlights new drug, molecular insight into triple negative breast cancers
Apr 14, 2014
Most breast cancers are treated by blocking their addictions, for example depriving estrogen-fueled tumors of estrogen. But what about breast cancers without these hormonal addictions? Read More
Cytomegalovirus may cause anemia in patients with kidney disease
Apr 14, 2014
A virus that is present in most people in a latent state may induce or exacerbate anemia in patients with kidney disease, according to a study appearing in an upcoming issue of the Journal of the... Read More
Growth factor receptors identified that may prompt the spread of lung cancer
Apr 13, 2014
Two cell surface receptors might be responsible for the most common form of lung cancer spreading to other parts of the body, according to a study led by the Translational Genomics Research Institute... Read More
Commission suggests improvements to cancer care in China, India and Russia
Apr 12, 2014
The Lancet Oncology publish the findings of a special commission formed to analyze the quality of cancer care in three large countries that present major health care challenges. Read More
Copper starvation could be promising treatment for some cancers
Apr 11, 2014
Researchers who found some cancers caused by a mutation in the BRAF gene need copper to fuel tumor growth, suggest they may be treatable with drugs that block copper absorption. Read More
Moffitt Cancer Center begins Phase I clinical trial of new immunotherapy
Apr 11, 2014
Moffitt Cancer Center has initiated a phase I clinical trial for a new immunotherapy drug, ID-G305, made by Immune Design. Read More
Phase 3 results announced for paediatric study of investigational therapy Eloctate(TM) for haemophilia A
Apr 11, 2014
Biogen Idec and Swedish Orphan Biovitrum AB (Sobi) have released positive top-line results of the Kids A-LONG Phase 3 clinical study that evaluated the safety and efficacy of Eloctate(TM), an... Read More
A high-fat diet can increase risk of certain types of breast cancer
Apr 11, 2014
High total and saturated fat intake were associated with greater risk of estrogen receptor- and progesterone receptor-positive (ER+PR+) breast cancer (BC), and human epidermal growth factor 2... Read More
Previous Page Next Page